Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Erlotinib can cause nonscarring hair loss and itchy skin.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Oral bicalutamide is safe and effective for female hair loss.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.